Literature DB >> 6824076

Nephron site of effect of nonsteroidal anti-inflammatory drugs on solute excretion in humans.

S Kaojarern, P Chennavasin, S Anderson, D C Brater.   

Abstract

Indomethacin and other nonsteroidal anti-inflammatory drugs (NSAIDs) decrease solute excretion when administered acutely to normal subjects. We performed clearance studies during water loading of 10 normal volunteers and during hydropenia in eight additional subjects to determine the nephron site of this effect using indomethacin and carprofen as inhibitors of prostaglandin (PG) synthesis. Their administration decreased fractional excretion of sodium, chloride, and volume. During water loading, fractional clearance of free water decreased from 0.13 +/- 0.04 during the control study to 0.09 +/- 0.03 and 0.06 +/- 0.02 with indomethacin and carprofen, respectively. However, fractional delivery of solute to the dilution segment decreased in parallel such that free water clearance corrected for delivery did not change with either drug. In humans, therefore, the decrement in solute excretion that occurs with administration of NSAIDs occurs prior to the diluting segment. During hydropenia, free water reabsorption relative to osmolar clearance increased (P less than 0.01). In both studies, neither the marker of renal perfusion or of proximal nephron function changed with inhibition of PG synthesis. The data indicate that at the tubular level, NSAIDs increase solute reabsorption at the medullary segment of the thick ascending limb of the loop of Henle. Therefore, a physiologic role of renal prostaglandins at this nephron site is implied.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824076     DOI: 10.1152/ajprenal.1983.244.2.F134

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Effects of flurbiprofen on renal function in patients with moderate renal insufficiency.

Authors:  M D Murray; P K Greene; D C Brater; A K Manatunga; S D Hall
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

2.  Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin.

Authors:  M J Webberley; J A Murray
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

Review 3.  Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure.

Authors:  J Feenstra; D E Grobbee; A Mosterd; B H Stricker
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

4.  Urinary nitrite excretion and urinary variables in patients with primary nocturnal frequency of micturition: effects of indomethacin suppositories.

Authors:  Noori S Al-Waili; Thia N Al-Waili; Ali N Al-Waili; Khelod Y Saloom
Journal:  World J Urol       Date:  2005-09-27       Impact factor: 4.226

5.  Renal handling and effects of S(+)-ibuprofen and R(-)-ibuprofen in the rat isolated perfused kidney.

Authors:  P G Cox; W M Moons; F G Russel; C A van Ginneken
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

6.  The effects of naproxen and sulindac on renal function and their interaction with hydrochlorothiazide and piretanide in man.

Authors:  J J Dixey; F H Noormohamed; A F Lant; D A Brewerton
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

Review 7.  Nephrotoxic drugs.

Authors:  S A Mendoza
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

8.  Interactive effects of indomethacin, angiotensin II and frusemide on renal haemodynamics and natriuresis in man.

Authors:  J G Motwani; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1994-04       Impact factor: 4.335

9.  Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus.

Authors:  T Höhler; G Teuber; R Wanitschke; K H Meyer zum Büschenfeld
Journal:  Clin Investig       Date:  1994-10

10.  Urinary chemical fingerprint left behind by repeated NSAID administration: Discovery of putative biomarkers using artificial intelligence.

Authors:  Liam E Broughton-Neiswanger; Sol M Rivera-Velez; Martin A Suarez; Jennifer E Slovak; Pablo E Piñeyro; Julianne K Hwang; Nicolas F Villarino
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.